2026 NPPES data Oncology Pharmacist NPI 1083013486 PHARMD
Verify on CMS →

JAE RYU, PHARMD

Oncology Pharmacist in PHILADELPHIA, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
What the federal data reveals: JAE RYU, PHARMD is a Oncology Pharmacist ([object Object]) practicing in PHILADELPHIA, Pennsylvania .

What stands out: JAE RYU, PHARMD specializes in Oncology Pharmacist and practices in PHILADELPHIA, Pennsylvania, listed in the federal CMS National Provider Identifier registry. Every detail on this page comes straight from federal CMS records, with no proprietary rating applied.

JAE RYU, PHARMD at a glance

Quality data not reported

NPI registry status

Active

Issued 08/21/2014

NPI 1083013486

Primary specialty

Oncology Pharmacist

Niche

1,699 US NPIs in this specialty

Specialty distribution in Pennsylvania

How Oncology Pharmacist compares to other specialties among Pennsylvania providers

Pennsylvania providers

Oncology Pharmacist share within Pennsylvania

1. Oncology Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Oncology Pharmacist share within Pennsylvania

Specialty board-certification context

Estimated specialty board-certified rate — Oncology Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Oncology Pharmacist ABMS/AOA estimate

Est. board-certified rate (Oncology Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Oncology Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JAE RYU, PHARMD is a Oncology Pharmacist provider practicing in PHILADELPHIA, Pennsylvania, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: PHARMD. NPI: 1083013486. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

JAE RYU, PHARMD appears in the CMS NPPES registry as a Oncology Pharmacist provider holding PHARMD credentials at 3900 WOODLAND AVE, PHILADELPHIA, PA, 19104, with a listed phone of (215) 823-5800. NPI 1083013486 was issued on 08/21/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what RYU most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D prescribing data is not currently published for this NPI, which typically means the provider either wrote fewer than 11 Part D claims in the most recent reporting year, does not participate in Medicare, or practices in a specialty that rarely prescribes outpatient drugs. Absence of prescribing data is not a quality signal — many Oncology Pharmacist providers operate outside Part D entirely.

Oncology Pharmacist is a narrow specialty nationwide, with 1,699 enrolled providers across 50 states and an average of 160 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3900 WOODLAND AVE
PHILADELPHIA, PA 19104

Provider Details

NPI 1083013486
Specialty Oncology Pharmacist
Credentials PHARMD
Gender Male
NPI Issued 08/21/2014

License & disciplinary context — Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to JAE RYU, PHARMD. To verify JAE RYU, PHARMD's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Oncology Pharmacist Overview

How JAE RYU, PHARMD fits within the Oncology Pharmacist landscape nationally.

1,699
Oncology Pharmacist Providers in US
50
States with Oncology Pharmacist
160
Avg Claims per Provider

Nearby Oncology Pharmacist Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as RYU.

Compare Oncology Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is JAE RYU, PHARMD's specialty?
JAE RYU, PHARMD specializes in Oncology Pharmacist and practices in PHILADELPHIA, Pennsylvania. Credentials: PHARMD.
Where is JAE RYU, PHARMD located?
JAE RYU, PHARMD is located at 3900 WOODLAND AVE, PHILADELPHIA, PA, 19104. Phone: (215) 823-5800.
What is JAE RYU, PHARMD's NPI number?
JAE RYU, PHARMD's National Provider Identifier (NPI) is 1083013486, issued on 08/21/2014.
How many Oncology Pharmacist providers are there in the US?
There are 1,699 Oncology Pharmacist providers across 50 states in the US. The average Oncology Pharmacist provider writes 160 Medicare Part D claims per year.
Does JAE RYU, PHARMD accept Medicare?
JAE RYU, PHARMD appears in CMS Medicare data. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JAE RYU, PHARMD's credentials?
JAE RYU, PHARMD's NPI is 1083013486 with credentials PHARMD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology